{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:51:55Z","timestamp":1791805915300,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growing evidence has highlighted the roles of circular RNAs (circRNAs) in non-small-cell lung cancer (NSCLC), however, their roles in NSCLC glycolysis remains poorly understood. CircRNAs microarray profiles discovered a novel exon-derived circRNA, circSLC25A16 (hsa_circ_0018534), in NSCLC tissue samples. In NSCLC samples, high-expression of circSLC25A16 was associated with unfavorable prognosis. Cellular experiments revealed that circSLC25A16 accelerated the glycolysis and proliferation of NSCLC cells. Besides, circSLC25A16 knockdown repressed the in vivo growth by xenograft assays. RNA-fluorescence in situ hybridization (RNA-FISH) illustrated that circSLC25A16 and miR-488-3p were both located in cytoplasm. Mechanistic experiments demonstrated that circSLC25A16 interacts with miR-488-3p\/HIF-1\u03b1, which activates lactate dehydrogenase A (LDHA) by facilitating its transcription. Collectively, present research reveals the crucial function of circSLC25A16 on NSCLC glycolysis through miR-488-3p\/HIF-1\u03b1\/LDHA, suggesting the underlying pathogenesis for NSCLC and providing a therapeutic strategy for precise treatment.<\/jats:p>","DOI":"10.1038\/s41419-020-2635-5","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T11:05:52Z","timestamp":1591614352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Circular RNA circSLC25A16 contributes to the glycolysis of non-small-cell lung cancer through epigenetic modification"],"prefix":"10.1038","volume":"11","author":[{"given":"Hong","family":"Shangguan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"2635_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-019-0996-6","volume":"14","author":"S Rao","year":"2019","unstructured":"Rao, S. et al. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer. J. Cardiothorac. Surg. 14, 197 (2019).","journal-title":"J. Cardiothorac. Surg."},{"key":"2635_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0852-9","volume":"21","author":"A Friedlaender","year":"2019","unstructured":"Friedlaender, A., Banna, G. L., Buffoni, L. & Addeo, A. Poor-performance status assessment of patients with non-small cell lung cancer remains vague and blurred in the immunotherapy era. Curr. Oncol. Rep. 21, 107 (2019).","journal-title":"Curr. Oncol. Rep."},{"key":"2635_CR3","first-page":"161","volume":"10","author":"H Inoue","year":"2019","unstructured":"Inoue, H. & Okamoto, I. Immune checkpoint inhibitors for the treatment of unresectable stage III non-small cell lung cancer: emerging mechanisms and perspectives. Lung Cancer 10, 161\u2013170 (2019).","journal-title":"Lung Cancer"},{"key":"2635_CR4","first-page":"949","volume":"41","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Clinical research and drug review of epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer. Zhonghua zhong liu za zhi [Chin. J. Oncol.] 41, 949\u2013952 (2019).","journal-title":"Zhonghua zhong liu za zhi [Chin. J. Oncol.]"},{"key":"2635_CR5","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.3389\/fimmu.2018.02977","volume":"9","author":"L Yang","year":"2018","unstructured":"Yang, L., Fu, J. & Zhou, Y. Circular RNAs and their emerging roles in immune regulation. Front. Immunol. 9, 2977 (2018).","journal-title":"Front. Immunol."},{"key":"2635_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3389\/fphys.2018.01262","volume":"9","author":"LM Holdt","year":"2018","unstructured":"Holdt, L. M., Kohlmaier, A. & Teupser, D. Circular RNAs as therapeutic agents and targets. Front. Physiol. 9, 1262 (2018).","journal-title":"Front. Physiol."},{"key":"2635_CR7","doi-asserted-by":"publisher","unstructured":"Li, Y., Ge, Y. Z., Xu, L. & Jia, R. Circular RNA ITCH: a novel tumor suppressor in multiple cancers. Life Sci. 117176. https:\/\/doi.org\/10.1016\/j.lfs.2019.117176. (2019).","DOI":"10.1016\/j.lfs.2019.117176"},{"key":"2635_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.mam.2019.10.006","volume":"70","author":"J Liu","year":"2019","unstructured":"Liu, J., Li, D., Luo, H. & Zhu, X. Circular RNAs: the star molecules in cancer. Mol. Asp. Med. 70, 141\u2013152 (2019).","journal-title":"Mol. Asp. Med."},{"key":"2635_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1177\/0963689718806818","volume":"27","author":"SW Wang","year":"2018","unstructured":"Wang, S. W., Liu, Z. & Shi, Z. S. Non-coding RNA in acute ischemic stroke: mechanisms, biomarkers and therapeutic targets. Cell Transplant. 27, 1763\u20131777 (2018).","journal-title":"Cell Transplant."},{"key":"2635_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1111-2","volume":"18","author":"PF Zhang","year":"2019","unstructured":"Zhang, P. F. et al. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol. Cancer 18, 179 (2019).","journal-title":"Mol. Cancer"},{"key":"2635_CR11","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/jcb.29484","volume":"121","author":"P Gao","year":"2020","unstructured":"Gao, P., Wang, Z., Hu, Z., Jiao, X. & Yao, Y. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4\/MADD activation. J. Cell. Biochem. 121, 2632\u20132642 (2020).","journal-title":"J. Cell. Biochem."},{"key":"2635_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0935-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1\/mTOR pathway. Mol. Cancer 18, 20 (2019).","journal-title":"Mol. Cancer"},{"key":"2635_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00432-017-2576-2","volume":"144","author":"MM Jiang","year":"2018","unstructured":"Jiang, M. M. et al. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis. J. Cancer Res. Clin. Oncol. 144, 667\u2013674 (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2635_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2019.05.032","volume":"44","author":"S Wei","year":"2019","unstructured":"Wei, S. et al. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p. EBioMedicine 44, 182\u2013193 (2019).","journal-title":"EBioMedicine"},{"key":"2635_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/1759-7714.13329","volume":"11","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer. Thoracic Cancer, 11, 875\u2013887 (2020).","journal-title":"Thoracic Cancer,"},{"key":"2635_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12013-019-00895-0","volume":"78","author":"C Jin","year":"2020","unstructured":"Jin, C. et al. CircMYC regulates glycolysis and cell proliferation in melanoma. Cell Biochem. Biophys. 78, 77\u201388 (2020).","journal-title":"Cell Biochem. Biophys."},{"key":"2635_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/1878-0261.12629","volume":"14","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol. Oncol. 14, 539\u2013555 (2020).","journal-title":"Mol. Oncol."},{"key":"2635_CR18","first-page":"6838","volume":"11","author":"Y Wei","year":"2019","unstructured":"Wei, Y., Zhang, Y., Meng, Q., Cui, L. & Xu, C. Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA. Am. J. Transl. Res. 11, 6838\u20136849 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"2635_CR19","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.3390\/ijms20133296","volume":"20","author":"X Zhao","year":"2019","unstructured":"Zhao, X., Cai, Y. & Xu, J. Circular RNAs: biogenesis, mechanism, and function in human cancers. Int. J. Mol. Sci. 20, 3296 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2635_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41418-019-0423-5","volume":"27","author":"W Zhao","year":"2020","unstructured":"Zhao, W. et al. Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via feedback loop. Cell Death Differ. 27, 919\u2013933 (2020).","journal-title":"Cell Death Differ."},{"key":"2635_CR21","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/CM9.0000000000000465","volume":"132","author":"D Li","year":"2019","unstructured":"Li, D., Yang, Y., Li, Z. Q., Li, L. C. & Zhu, X. H. Circular RNAs: from biogenesis and function to diseases. Chin. Med. J. 132, 2457\u20132464 (2019).","journal-title":"Chin. Med. J."},{"key":"2635_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li, X., Yang, L. & Chen, L. L. The biogenesis, functions, and challenges of circular RNAs. Mol. cell 71, 428\u2013442 (2018).","journal-title":"Mol. cell"},{"key":"2635_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s13046-019-1351-4","volume":"38","author":"J Jin","year":"2019","unstructured":"Jin, J. et al. Cardamonin inhibits breast cancer growth by repressing HIF-1alpha-dependent metabolic reprogramming. J. Exp. Clin. Cancer Res. 38, 377 (2019).","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2635-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2635-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2635-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:01:32Z","timestamp":1670252492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2635-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["2635"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2635-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"19 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"437"}}